Kurt Dieck

Executive Advisory Board

Kurt Dieck

Executive Advisory Board

Chief Executive Officer
Addisen Advisors

Kurt is a seasoned executive with a broad base of experiences. He is the founder and CEO of Addisen Advisors, a strategy and M&A advisory firm.

Kurt has spent nearly his entire career in the Healthcare space. He started his career with Arthur Andersen where he became Partner in 1998. In 2002 he joined Cardinal Health as a Senior Executive where he had increasing responsibilities including Strategy & Business Development, Integration, Pricing and Competitive Intelligence, and his last 2 years was SVP of Business Execution for the $100 billion pharmaceutical distribution business. Finally, Kurt was the President and CEO of Biosortia Pharmaceuticals, a natural products drug discovery company focus in the areas of cancer, infectious disease and CNS. During his tenure Biosortia created a robust pipeline as well as key partnerships with companies including AstraZeneca, Lilly, and Eisai.

Kurt currently serves on the boards of Southern Anesthesia & Surgical, Inc. and Maxor National Pharmacy Services Company. He was previously on the board of Genoa Healthcare that was sold in 2014.